0.00Open0.00Pre Close0 Volume0 Open Interest1.50Strike Price0.00Turnover0.00%IV53.56%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.58Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Macrogenics Stock Discussion
f@#$%^&* up
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration With Incyte
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
No comment yet